Citations

Mayo Clinic

Showing 10 of 108523 citations.

Association of Hospital Participation in a Surgical Outcomes Monitoring Program With Inpatient Complications and Mortality
Etzioni, David A. , Wasif, Nabil , Dueck, Amylou C. , Hohmann, Samuel F. , Naessens, James M. , Mathur, Amit K. , Habermann, Elizabeth B. , Cima, Robert R. , Dueck, A. C. , Habermann, Elizabeth

JAMA | February 3, 2015 | Volume: 313 | Issue: 5 | Pages: 505

10.1001/jama.2015.90 | PMID 25647206 Get It

Musculoskeletal Sarcoma: Update on Imaging of the Post-treatment Patient
Garner, Hillary W. , Kransdorf, Mark J. , Garner, Hillary W

Canadian Association of Radiologists Journal | February 3, 2015 | Volume: 67 | Issue: 1 | Pages: 12-20

10.1016/j.carj.2014.11.002 | PMID 25660298 Get It

Post-treatment imaging of musculoskeletal sarcoma remains challenging, but newer imaging techniques are improving our ability to recognize both local and distant recurrence and accurately distinguish local recurrence from post-treatment change. We review recent advances in dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping and positron emission tomography/computed tomography in the post-treatment follow-up of musculoskeletal sarcoma. We also describe our multidisciplinary sarcoma team approach to patient care and the essential role of the radiologist in the clinical follow-up scheme.
Description and pilot evaluation of the Metabolic Irregularities Narrowing down Device software: a case analysis of physician programming
Kashiouris, Markos , Herasevich, Vitaly , Goldberg, A.David, Albrecht, Charles R., Miljković, Miloš D. , Herasevich, Vitaly

Journal of Community Hospital Internal Medicine Perspectives | February 3, 2015 | Volume: 5 | Issue: 1 | Pages: 25793

10.3402/jchimp.v5.25793 | PMID 25656664 Get It

BRCA1 Circos: a visualisation resource for functional analysis of missense variants
Jhuraney, Ankita, Velkova, Aneliya, Johnson, Randall C. , Kessing, Bailey, Carvalho, Renato S. , Whiley, Phillip J , Spurdle, Amanda B. , Caputo, Sandrine M. , Millot, Gaël A. , Vega, Ana , Coquelle, Nicolas , Galli, Alvaro , Eccles, Diana , Blok, Marinus J. , Luijt, Rob B. van der , Pena, Marta Santamariña, Donenberg, Talia , Macháčková, Eva , Thomas, Simon , Vallée, Maxime , Tavtigian, Sean V. , Glover, J. N. Mark , Carvalho, Marcelo A. , Brody, Lawrence C. , Monteiro, Álvaro N.A. , Vreeswijk, Maaike P.G. , Pal, Tuya , Neuhausen, Susan L. , Couch, Fergus J. , Sharan, Shyam K. , Spurdle, Amanda B , Eccles, Diana , Monteiro, Alvaro N , Vega, Ana , van der Luijt, Rob B

Journal of Medical Genetics | February 3, 2015 | Volume: 52 | Issue: 4 | Pages: 224-230

10.1136/jmedgenet-2014-102766 | PMID 25643705 Get It

Background Inactivating germline mutations in the tumour suppressor gene BRCA1 are associated with a significantly increased risk of developing breast and ovarian cancer. A large number (>1500) of unique BRCA1 variants have been identified in the population and can be classified as pathogenic, non-pathogenic or as variants of unknown significance (VUS). Many VUS are rare missense variants leading to single amino acid changes. Their impact on protein function cannot be directly inferred from sequence information, precluding assessment of their pathogenicity. Thus, functional assays are critical to assess the impact of these VUS on protein activity. BRCA1 is a multifunctional protein and different assays have been used to assess the impact of variants on different biochemical activities and biological processes. Methods and results To facilitate VUS analysis, we have developed a visualisation resource that compiles and displays functional data on all documented BRCA1 missense variants. BRCA1 Circos is a web-based visualisation tool based on the freely available Circos software package. The BRCA1 Circos web tool (http://research.nhgri.nih.gov/bic/circos/) aggregates data from all published BRCA1 missense variants for functional studies, harmonises their results and presents various functionalities to search and interpret individual-level functional information for each BRCA1 missense variant. Conclusions This research visualisation tool will serve as a quick one-stop publically available reference for all the BRCA1 missense variants that have been functionally assessed. It will facilitate meta-analysis of functional data and improve assessment of pathogenicity of VUS.
Muscle-derived stem cell seeded fibrin gel interposition produces greater tendon strength and stiffness than collagen gel in vitro
Ozasa, Yasuhiro , Amadio, Peter C. , Gingery, Anne

Journal of Hand Surgery (European Volume) | February 3, 2015 | Volume: 40 | Issue: 7 | Pages: 747-749

10.1177/1753193414568780 | PMID 25646141 Get It

Characterizing patterns of endothelialization following coil embolization: a whole-mount, dual immunostaining approach
Ding, Yong-Hong, Rezek, Issa, Kallmes, David F. , Kadirvel, Ramanathan , Dai, Daying , Ding, Yonghong

Journal of NeuroInterventional Surgery | February 2, 2015 | Volume: 8 | Issue: 4 | Pages: 402-406

10.1136/neurintsurg-2014-011513 | PMID 25646129 Get It

Background The extent, rate, and source of endothelialization following coil embolization of saccular aneurysms remains poorly understood. We performed a whole tissue mount, dual immunohistochemical analysis of experimental aneurysms to characterize the state of endothelialization over time after platinum coil embolization. Method and material Elastase-induced rabbit aneurysms were created and treated with bare platinum coils. Samples were harvested at 4 and 8 weeks (n=6 for each). En face whole tissue mount staining with antibodies to CD31 and α-smooth muscle actin was used to identify endothelial cells and smooth muscle cells, respectively. Sytox green stain was used to demonstrate nuclear morphology for identification of inflammatory cells. The extent of endothelialization was measured in relation to the aneurysm neck–parent artery interface. Results At 4 weeks after coil embolization, very localized membranous tissue and neoendothelial cells were detected on the coil loops immediately adjacent to the parent artery–neck interface, but the remainder of the coil loops remained devoid of endothelial cells. At 8 weeks neoendothelial cells were more confluent over the coils than at 4 weeks, and extended up to 900 µm from the parent artery–neck interface. However, the surfaces of the coils farther away than this region harbored no endothelial cells. Scattered inflammatory cells, including neutrophils and monocytes, were seen on the coil surface at the neck central area, where the coil surface was bare at the 4 and 8 weeks’ follow-up. Conclusions Platinum coil embolization supports gradual but limited endothelialization, where endothelial cells migrate directly from the adjacent parent artery.
Plasma butyrylcholinesterase regulates ghrelin to control aggression
Chen, Vicky Ping , Gao, Yang , Geng, Liyi, Parks, Robin J. , Pang, Yuan‐Ping , Brimijoin, Stephen , Pang, Yuan-Ping

Proceedings of the National Academy of Sciences | February 2, 2015 | Volume: 112 | Issue: 7 | Pages: 2251-2256

10.1073/pnas.1421536112 | PMID 25646463 Get It

Significance Butyrylcholinesterase (BChE), a common plasma enzyme, has been known for decades but its real physiological roles are just beginning to emerge. Although BChE eliminates the neurotransmitter acetylcholine, it is not vital for locomotion, cognition, or other cholinergic functions. Nevertheless, we now find that circulating BChE has a large impact on aggressive behavior in mice that is attributable to its ability to inactivate ghrelin, a peptide hormone involved in hunger, feeding, and stress. A key observation was decreased fighting among group-housed male mice overexpressing BChE after viral gene transfer. In contrast, BChE knockout mice exhibited increased fighting. These effects mirrored changes in plasma levels of active ghrelin. Controlling them might offer therapeutic potential for certain behavioral disorders.
Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)
McCall, Linda, Ahrendt, Gretchen , Wilke, Lee G. , Le‐Petross, Huong T. , Hunt, Kelly K. , McCall, Linda M, Mittendorf, Elizabeth A, Ahrendt, Gretchen M, Le-Petross, Huong T, Boughey, Judy C. , Ballman, Karla V. , Mittendorf, EA

Journal of Clinical Oncology | February 2, 2015 | Volume: 33 | Issue: 30 | Pages: 3386-3393

10.1200/jco.2014.57.8401 | PMID 25646192 Get It

Purpose The American College of Surgeons Oncology Group Z1071 trial reported a 12.6% false-negative rate (FNR) for sentinel lymph node (SLN) surgery after neoadjuvant chemotherapy (NAC) in cN1 disease. Patients were not selected for surgery based on response, but a secondary end point was to determine whether axillary ultrasound (AUS) after NAC after fine-needle aspiration cytology can identify abnormal nodes and guide patient selection for SLN surgery. Patients and Methods Patients with T0-4, N1-2, M0 breast cancer underwent AUS after neoadjuvant chemotherapy. AUS images were centrally reviewed and classified as normal or suspicious lymph nodes. AUS findings were tested for association with pathologic nodal status and SLN FNR. The impact of AUS results to select patients for SLN surgery to reduce the FNR was assessed. Results Postchemotherapy AUS images were reviewed for 611 patients. One hundred thirty (71.8%) of 181 AUS-suspicious patients were node positive at surgery compared with 243 (56.5%) of 430 AUS-normal patients (P < .001). Patients with AUS-suspicious nodes had a greater number of positive nodes and greater metastasis size (P < .001). The SLN FNR was not different based on AUS results; however, using a strategy where only patients with normal AUS undergo SLN surgery would potentially reduce the FNR in Z1071 patients with ≥ two SLNs removed from 12.6% to 9.8% when preoperative AUS results are considered as part of SLN surgery. Conclusion AUS is recommended after chemotherapy to guide axillary surgery. An FNR of 9.8% with the combination of AUS and SLN surgery would be acceptable for the adoption of SLN surgery for women with node-positive breast cancer treated with neoadjuvant chemotherapy.
Smoking Is Associated with Acute and Chronic Prostatic Inflammation: Results from the REDUCE Study
Moreira, Daniel M. , Nickel, J. Curtis , Gerber, Leah, Müller, Roberto L. , Andriole, Gerald L. , Castro‐Santamaria, Ramiro , Freedland, Stephen J.

Cancer Prevention Research | February 2, 2015 | Volume: 8 | Issue: 4 | Pages: 312-317

10.1158/1940-6207.capr-14-0260 | PMID 25644151 Get It

Abstract Both anti- and proinflammatory effects of cigarette smoking have been described. As prostate inflammation is common, we hypothesized smoking could contribute to prostate inflammation. Thus, we evaluated the association of smoking status with acute and chronic inflammation within the prostate of men undergoing prostate biopsy. We retrospectively analyzed 8,190 men ages 50 to 75 years with PSA levels between 2.5 and 10 ng/mL enrolled in the Reduction by Dutasteride of Prostate Cancer Events study. Smoking status was self-defined as never, former, or current. Prostate inflammation was assessed by systematic central review blinded to smoking status. The association of smoking with inflammation in the baseline, 2-year, and 4-year biopsies was evaluated with univariable and multivariable logistic regressions. At study enrollment, 1,233 (15%), 3,203 (39%), and 3,754 (46%) men were current, former, and never smokers, respectively. Current smokers were significantly younger and had smaller prostates than former and never smokers (all P &lt; 0.05). Former smokers were significantly heavier than current and never smokers (P &lt; 0.001). Acute and chronic prostate inflammations were identified in 1,261 (15%) and 6,352 (78%) baseline biopsies, respectively. In univariable analysis, current smokers were more likely to have acute inflammation than former (OR, 1.35; P, 0.001) and never smokers (OR, 1.36; P, 0.001). The results were unchanged at 2- and 4-year biopsies. In contrast, current smoking was linked with chronic inflammation in the baseline biopsy, but not at 2- and 4-year biopsies. In conclusion, among men undergoing prostate biopsy, current smoking was independently associated with acute and possibly chronic prostate inflammations. Cancer Prev Res; 8(4); 312–7. ©2015 AACR.
Immunophenotypic features by multiparameter flow cytometry can help distinguish low grade B‐cell lymphomas with plasmacytic differentiation from plasma cell proliferative disorders with an unrelated clonal B‐cell process
Rosado, Flavia, Morice, William G. , He, Rong , Howard, Matthew T., Timm, Michael, McPhail, Ellen D. , Rosado, Flavia G, Morice, William George , McPhail, Ellen Darcy

British Journal of Haematology | February 2, 2015 | Volume: 169 | Issue: 3 | Pages: 368-376

10.1111/bjh.13303 | PMID 25644063 Get It

SummaryHighly sensitive flow cytometry studies may incidentally identify B cell clones when used to assess plasma cell clonality in bone marrows. Clinical history, which can help differentiate related clones (low grade B cell lymphoma with plasmacytic differentiation/LBCL‐PD) from unrelated ones (plasma cell proliferative disorder (PCPD) with an unrelated B cell clone), is often unavailable in referred specimens. We sought to identify morphologic or phenotypic features that would help predict the significance of these clones in the absence of history. We included only cases with identical light chain B and plasma cell clones, as determined by 6‐color flow cytometry with additional DNA ploidy analysis, in which the relationship between clones could be established by review of medical records. There were 26 cases; 18 were related (14 were Waldenstrom macroglobulinemia) and eight were unrelated (seven multiple myeloma). Features seen exclusively in LBCL‐PD include CD19+/CD45+ clonal plasma cell phenotype (66·7%, P = 0·0022) and morphologic features such as paratrabecular bone marrow involvement, increased mast cells, and plasma cells surrounding B‐cell nodules. Aneuploidy was identified exclusively in PCPD cases (75%, P = 0·000028). We conclude that CD19+/CD45+ clonal plasma cell phenotype and aneuploidy are useful in distinguishing related clones (LBCL‐PD) from unrelated clones (PCPD).